A study published by JAMA Pediatrics demonstrates maternally derived antibodies’ potential to provide neonatal protection from SARS-CoV-2 infection.
This study’s findings indicate an ‘efficient transplacental transfer of SARS-CoV-2 IgG antibodies supports the potential for maternally derived antibodies to provide neonatal protection from SARS-CoV-2 infection.’
These researchers stated on January 29, 2021, ‘Our findings align with current evidence that suggests that although placental and neonatal SARS-CoV-2 transmission may occur, such events are not common.’
Read More
